330 related articles for article (PubMed ID: 24283840)
1. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.
Quiralte J; Justicia JL; Cardona V; Dávila I; Moreno E; Ruiz B; García MA
Immunotherapy; 2013 Dec; 5(12):1295-303. PubMed ID: 24283840
[TBL] [Abstract][Full Text] [Related]
2. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
[TBL] [Abstract][Full Text] [Related]
3. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
[TBL] [Abstract][Full Text] [Related]
4. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
Asero R
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
[TBL] [Abstract][Full Text] [Related]
5. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
[TBL] [Abstract][Full Text] [Related]
6. Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases.
Fernández-Távora L; Justicia JL; Moreno C; Tabar AI; Vidal C
Expert Opin Drug Saf; 2011 Nov; 10(6):947-55. PubMed ID: 21770817
[TBL] [Abstract][Full Text] [Related]
7. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
[TBL] [Abstract][Full Text] [Related]
8. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
[TBL] [Abstract][Full Text] [Related]
9. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010.
Santos N; Pereira AM; Silva R; Torres da Costa J; Plácido JL
Allergol Immunopathol (Madr); 2015; 43(1):25-31. PubMed ID: 24661594
[TBL] [Abstract][Full Text] [Related]
12. Safety of cluster specific immunotherapy with a modified high-dose house dust mite extract.
Nieto García A; Nevot Falcó S; Carrillo Díaz T; Cumplido Bonny JA; Izquierdo Calderón JP; Hernández-Peña J
Eur Ann Allergy Clin Immunol; 2013 May; 45(3):78-83. PubMed ID: 23862396
[TBL] [Abstract][Full Text] [Related]
13. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice.
Copenhaver CC; Parker A; Patch S
Ann Allergy Asthma Immunol; 2011 Nov; 107(5):441-7. PubMed ID: 22018617
[TBL] [Abstract][Full Text] [Related]
14. Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation.
Pfaar O; van Twuijver E; Hecker H; Boot JD; van Ree R; Klimek L
Int Arch Allergy Immunol; 2013; 160(4):420-4. PubMed ID: 23183541
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
[TBL] [Abstract][Full Text] [Related]
16. Cluster protocols in SCIT: enough evidence for practical use?
Pfaar O; Leitzbach S; Hörmann K; Klimek L
Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):188-93. PubMed ID: 20410818
[TBL] [Abstract][Full Text] [Related]
17. Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio.
Pfaar O; Jung K; Wolf H; Decot E; Kleine-Tebbe J; Klimek L; Wüstenberg E
Allergy; 2012 May; 67(5):630-7. PubMed ID: 22385366
[TBL] [Abstract][Full Text] [Related]
18. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
19. One century of allergen-specific immunotherapy for respiratory allergy.
Incorvaia C; Frati F
Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
[TBL] [Abstract][Full Text] [Related]
20. Allergen immunotherapy for respiratory allergy: to what extent can the risk of systemic reactions be reduced?
Incorvaia C; Pucciarini F; Makri E; Gritti BL; Ridolo E
Expert Opin Drug Saf; 2020 Jul; 19(7):843-848. PubMed ID: 32511028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]